EconomyEditor's PickNewsWasatch Advisors increased stake in Frequency Therapeutics, Inc.

2 years ago346 min
imageStock Markets1 hour ago (Oct 02, 2020 01:30PM ET)

(C) Reuters. Wasatch Advisors increased stake in Frequency Therapeutics, Inc.

On the 30th of September, Wasatch Advisors bought 2.2 million Frequency Therapeutics, Inc. (FREQ) shares for $42 million at an average price of $19.21 per share.
Shares of Frequency Therapeutics, Inc. are up 3.49% since the transaction.

Wasatch Advisors’s holding in Frequency Therapeutics, Inc. increased to about 3.4 million shares with the purchase.

Wasatch Advisors first bought Frequency Therapeutics, Inc. stock in the fourth quarter of 2019.
Wasatch Advisors also owns Medpace Holdings, Inc. (NASDAQ:MEDP), ICON Public Limited Company (ICLR), MacroGenics, Inc. (NASDAQ:MGNX) and ChemoCentryx, Inc. (NASDAQ:CCXI).
Frequency Therapeutics, Inc. is its number three position by number of shares and market value among biotechnology & life sciences stocks.

Other investors who also added to their Frequency Therapeutics, Inc. shares include California State Teachers Retirement System.
Contrary to Wasatch Advisors, Millennium Management and Victory Capital Management sold all their FREQ shares.

Wasatch Advisors also sold all their shares in MIND Technology, Inc. (MIND), Lonestar Resources US Inc. (NASDAQ:LONE) and One Stop Systems, Inc. (NASDAQ:OSS).
The total value of the shares sold is estimated at around $16 million.

Additionally, Wasatch Advisors increased their share in Boot Barn Holdings, Inc. (NYSE:BOOT).
The total value of the shares bought is estimated at around $69 million.

Wasatch Advisors increased stake in Frequency Therapeutics, Inc.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Leave a Reply

Your email address will not be published. Required fields are marked *